| JYSB2100059 | 兔抗人胸腺细胞免疫球蛋白 | Rabbit Anti-human Thymocyte Immunoglobulin | Lyophilized | Biological Products | Supplementary Application | 2021-02-24 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Polyclonals SAS;Genzyme Europe BV | In Review | 2022-01-27 | view |
| JYSB2000645 | 注射用拉罗尼酶浓溶液 | laronidase | Injection | Biological Products | Supplementary Application | 2020-12-21 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Genzyme Europe BV | Certificate Issued | 2021-12-23 | view |
| JXHS2000125 | 盐酸决奈达隆片 | dronedarone hydrochloride | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-08-24 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi Winthrop Industrie;Sanofi-Aventis US LLC | Approval Completed-Pending Certificated | 2021-12-20 | view |
| JYSB2000609 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-11-16 | view |
| JYSB2000608 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-11-16 | view |
| JYSB2000606 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-11-16 | view |
| JYSB2000610 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-11-16 | view |
| JXHS2100012 | 注射用奥沙利铂 | oxaliplatin | Lyophilized | Chemical Drugs(2.4) | Import Drug Application | 2021-01-28 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Cenexi Laboratories Thissen SA | Certificate Issued | 2021-11-02 | view |
| JYHZ2100058 | 交联玻璃酸钠注射液 | | Injection | Chemical Drugs | License Renew | 2021-03-25 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Corporation | Certificate Issued | 2021-10-28 | view |
| JYSB2000607 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2020-12-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-10-21 | view |
| JYHZ2100057 | 交联玻璃酸钠注射液 | | Injection | Chemical Drugs | License Renew | 2021-03-25 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Corporation | Certificate Issued | 2021-10-19 | view |
| JXHS2000024 | 氯吡格雷阿司匹林片 | aspirin;Clopidogrel bisulfate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-03-18 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi KK;Sanofi Winthrop Industrie | Certificate Issued | 2021-10-11 | view |
| JYSB2000683 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Supplementary Application | 2021-01-01 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | Certificate Issued | 2021-09-22 | view |
| JXSS2000035 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-30 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | Certificate Issued | 2021-09-10 | view |
| JXSS2000034 | 度普利尤单抗注射液 | dupilumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-30 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis Groupe;Sanofi Winthrop Industrie | Certificate Issued | 2021-09-10 | view |
| JYHB2000659 | 注射用丙戊酸钠 | sodium valproate | Lyophilized | Chemical Drugs | Supplementary Application | 2020-05-28 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi SpA;Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-09-07 | view |
| JYHB2000658 | 注射用丙戊酸钠 | sodium valproate | Lyophilized | Chemical Drugs | Supplementary Application | 2020-06-15 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi SpA;Sanofi-Aventis Deutschland GmbH | Certificate Issued | 2021-09-07 | view |
| JXHS2000133 | 碳酸司维拉姆片 | sevelamer carbonate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-09-10 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Genzyme Ireland Ltd;Genzyme Europe BV | Certificate Issued | 2021-07-26 | view |
| JYHZ1900061 | 丙戊酸钠缓释片 | sodium valproate | Tablet, extended release | Chemical Drugs(5.1) | License Renew | 2019-03-11 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Sanofi Winthrop Industrie | Certificate Issued | 2021-07-08 | view |
| JYHB2002432 | 盐酸胺碘酮注射液 | amiodarone hydrochloride | Injection | Chemical Drugs | Supplementary Application | 2020-11-30 | 赛诺菲（中国）投资有限公司 | Sanofi (China) Investment Co Ltd;Sanofi-Aventis France;Sanofi Winthrop Industrie | In Review | 2021-05-09 | view |
